Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
27.00
+0.31 (1.16%)
At close: Jun 26, 2026, 4:00 PM EDT
27.09
+0.09 (0.32%)
After-hours: Jun 26, 2026, 7:23 PM EDT
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 354 employees as of December 31, 2025. The number of employees increased by 12 or 3.51% compared to the previous year.
Employees
354
Change (1Y)
12
Growth (1Y)
3.51%
Revenue / Employee
$1,174,079
Profits / Employee
-$6,712
Market Cap
3.38B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| Catalyst Pharmaceuticals | 182 |
ARQT News
- 17 days ago - Arcutis Biotherapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - Arcutis Biotherapeutics Transcript: AGM 2026 - Transcripts
- 23 days ago - New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology - GlobeNewsWire
- 4 weeks ago - Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Arcutis Biotherapeutics price target lowered to $34 from $35 at Morgan Stanley - TheFly
- 7 weeks ago - Arcutis Biotherapeutics reports Q1 EPS (9c), consensus (6c) - TheFly
- 7 weeks ago - Arcutis Biotherapeutics backs FY26 revenue view $480M-$495M, consensus $498.07M - TheFly